Indications/Uses: Indicated for the treatment of schizophrenia. It is effective in maintaining the clinical improvement during continuing therapy in patients who have shown initial treatment response. It is also indicated for short-term treatment of acute manic episode associated with bipolar I disorder. Olanzapine is also indicated for preventing recurrence of manic, mixed or depressive episodes in Bipolar I disorder

Indications/Uses: Used in the treatment of depression, panic disorder with or without agoraphobia, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.

Indications/Uses: It is given to the patients with atherosclerosis who are at risk of thromboembolic disorders such as myocardial infarction, peripheral arterial disease and stroke.

Indications/Uses: It is given by mouth for the treatment of schizophrenia and other psychoses and in the short-term treatment of mania associated with bipolar disorder.

Indications/Uses: Indicated for the treatment of schizophrenia. It is effective in maintaining the clinical improvement during continuing therapy in patients who have shown initial treatment response. It is also indicated for short-term treatment of acute manic episode associated with bipolar I disorder. Olanzapine is also indicated for preventing recurrence of manic, mixed or depressive episodes in Bipolar I disorder.

Indications/Uses: Used for the symptomatic relief of rheumatoid arthritis, osteoarthritis and acute gouty arthritis.

Indications/Uses: Used in the management of hypertension.

Indications/Uses: Edaravone (CONJUVON) is indicated for improvement of neurological symptoms, disorder of activities of daily living and functional disorder associated with acute ischemic stroke.